Angiotensin II receptor subtype AT1 and AT2 expression after heart transplantation

Lars Gullestad, Guy Haywood, Halfdan Aass, Heather Ross, Gail Yee, Thor Ueland, Odd Geiran, John Kjekshus, Svein Simonsen, Nanette Bishopric, Michael Fowler

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Objective: Cardiac hypertrophy appears early after heart transplantation, and may represent a myocardial response to injury. Recent evidence suggests that angiotensin II (Ang II) may promote growth through the AT1 and inhibit growth through the AT2 receptor subtypes. We therefore asked whether hypertrophy after heart transplantation is characterized by alterations in Ang 11 receptor gene expression. Methods: The expression of Ang II receptor subtypes, AT1 and AT2, was analyzed in right ventricular endomyocardial biopsies taken from 10 human donor hearts prior to implantation (controls) and from 17 heart transplant recipients, 11 studied during annual evaluation (> 1 year after transplantation) and 6 one week after transplantation. Competitive reverse transcription polymerase chain reaction (RT-PCR) was performed using synthetic RNA internal standards for both receptor subtypes. Results: AT1 and AT2 receptor mRNAs were detected in all samples. AT1 receptor mRNA decreased 4.5 fold (p < 0.01) and AT2 receptor mRNA 4.2 fold (p < 0.001) in transplant patients compared with controls. In the subgroup of patients examined one week after surgery AT1 was reduced relative to AT2 receptor mRNA, resulting in an altered ratio of AT1 to AT2 early after transplantation. There was no correlation between Ang II receptor levels and left ventricular wall thickness, and the decrease in receptor level did not correlate with any hemodynamic parameters, cyclosporine blood levels, or plasma renin, Ang II or pANP, except for a negative correlation between AT2 mRNA and plasma renin (r = -0.49,p = 0.05). Conclusions: Contrary to our expectations, mRNA for both Ang II receptors was downregulated after heart transplantation. The cause of myocardial hypertrophy after heart transplantation is still unclear, but the hypertrophy does not appear to be driven by increased transcription of the AT1 receptor.

Original languageEnglish
Pages (from-to)340-347
Number of pages8
JournalCardiovascular Research
Volume38
Issue number2
DOIs
StatePublished - May 1 1998
Externally publishedYes

Fingerprint

Angiotensin Receptors
Heart Transplantation
Messenger RNA
Hypertrophy
Transplantation
Renin
Angiotensin II
Cardiomegaly
Growth
Cyclosporine
Reverse Transcription
Down-Regulation
Hemodynamics
Tissue Donors
RNA
Transplants
Biopsy
Gene Expression
Polymerase Chain Reaction
Wounds and Injuries

Keywords

  • Angiotensin
  • Clinical
  • Gene expression
  • Heart
  • Human
  • Molecular biology
  • Receptors
  • Transplantation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Gullestad, L., Haywood, G., Aass, H., Ross, H., Yee, G., Ueland, T., ... Fowler, M. (1998). Angiotensin II receptor subtype AT1 and AT2 expression after heart transplantation. Cardiovascular Research, 38(2), 340-347. https://doi.org/10.1016/S0008-6363(98)00015-7

Angiotensin II receptor subtype AT1 and AT2 expression after heart transplantation. / Gullestad, Lars; Haywood, Guy; Aass, Halfdan; Ross, Heather; Yee, Gail; Ueland, Thor; Geiran, Odd; Kjekshus, John; Simonsen, Svein; Bishopric, Nanette; Fowler, Michael.

In: Cardiovascular Research, Vol. 38, No. 2, 01.05.1998, p. 340-347.

Research output: Contribution to journalArticle

Gullestad, L, Haywood, G, Aass, H, Ross, H, Yee, G, Ueland, T, Geiran, O, Kjekshus, J, Simonsen, S, Bishopric, N & Fowler, M 1998, 'Angiotensin II receptor subtype AT1 and AT2 expression after heart transplantation', Cardiovascular Research, vol. 38, no. 2, pp. 340-347. https://doi.org/10.1016/S0008-6363(98)00015-7
Gullestad, Lars ; Haywood, Guy ; Aass, Halfdan ; Ross, Heather ; Yee, Gail ; Ueland, Thor ; Geiran, Odd ; Kjekshus, John ; Simonsen, Svein ; Bishopric, Nanette ; Fowler, Michael. / Angiotensin II receptor subtype AT1 and AT2 expression after heart transplantation. In: Cardiovascular Research. 1998 ; Vol. 38, No. 2. pp. 340-347.
@article{ed0968a4c7244b209375551236597d73,
title = "Angiotensin II receptor subtype AT1 and AT2 expression after heart transplantation",
abstract = "Objective: Cardiac hypertrophy appears early after heart transplantation, and may represent a myocardial response to injury. Recent evidence suggests that angiotensin II (Ang II) may promote growth through the AT1 and inhibit growth through the AT2 receptor subtypes. We therefore asked whether hypertrophy after heart transplantation is characterized by alterations in Ang 11 receptor gene expression. Methods: The expression of Ang II receptor subtypes, AT1 and AT2, was analyzed in right ventricular endomyocardial biopsies taken from 10 human donor hearts prior to implantation (controls) and from 17 heart transplant recipients, 11 studied during annual evaluation (> 1 year after transplantation) and 6 one week after transplantation. Competitive reverse transcription polymerase chain reaction (RT-PCR) was performed using synthetic RNA internal standards for both receptor subtypes. Results: AT1 and AT2 receptor mRNAs were detected in all samples. AT1 receptor mRNA decreased 4.5 fold (p < 0.01) and AT2 receptor mRNA 4.2 fold (p < 0.001) in transplant patients compared with controls. In the subgroup of patients examined one week after surgery AT1 was reduced relative to AT2 receptor mRNA, resulting in an altered ratio of AT1 to AT2 early after transplantation. There was no correlation between Ang II receptor levels and left ventricular wall thickness, and the decrease in receptor level did not correlate with any hemodynamic parameters, cyclosporine blood levels, or plasma renin, Ang II or pANP, except for a negative correlation between AT2 mRNA and plasma renin (r = -0.49,p = 0.05). Conclusions: Contrary to our expectations, mRNA for both Ang II receptors was downregulated after heart transplantation. The cause of myocardial hypertrophy after heart transplantation is still unclear, but the hypertrophy does not appear to be driven by increased transcription of the AT1 receptor.",
keywords = "Angiotensin, Clinical, Gene expression, Heart, Human, Molecular biology, Receptors, Transplantation",
author = "Lars Gullestad and Guy Haywood and Halfdan Aass and Heather Ross and Gail Yee and Thor Ueland and Odd Geiran and John Kjekshus and Svein Simonsen and Nanette Bishopric and Michael Fowler",
year = "1998",
month = "5",
day = "1",
doi = "10.1016/S0008-6363(98)00015-7",
language = "English",
volume = "38",
pages = "340--347",
journal = "Cardiovascular Research",
issn = "0008-6363",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Angiotensin II receptor subtype AT1 and AT2 expression after heart transplantation

AU - Gullestad, Lars

AU - Haywood, Guy

AU - Aass, Halfdan

AU - Ross, Heather

AU - Yee, Gail

AU - Ueland, Thor

AU - Geiran, Odd

AU - Kjekshus, John

AU - Simonsen, Svein

AU - Bishopric, Nanette

AU - Fowler, Michael

PY - 1998/5/1

Y1 - 1998/5/1

N2 - Objective: Cardiac hypertrophy appears early after heart transplantation, and may represent a myocardial response to injury. Recent evidence suggests that angiotensin II (Ang II) may promote growth through the AT1 and inhibit growth through the AT2 receptor subtypes. We therefore asked whether hypertrophy after heart transplantation is characterized by alterations in Ang 11 receptor gene expression. Methods: The expression of Ang II receptor subtypes, AT1 and AT2, was analyzed in right ventricular endomyocardial biopsies taken from 10 human donor hearts prior to implantation (controls) and from 17 heart transplant recipients, 11 studied during annual evaluation (> 1 year after transplantation) and 6 one week after transplantation. Competitive reverse transcription polymerase chain reaction (RT-PCR) was performed using synthetic RNA internal standards for both receptor subtypes. Results: AT1 and AT2 receptor mRNAs were detected in all samples. AT1 receptor mRNA decreased 4.5 fold (p < 0.01) and AT2 receptor mRNA 4.2 fold (p < 0.001) in transplant patients compared with controls. In the subgroup of patients examined one week after surgery AT1 was reduced relative to AT2 receptor mRNA, resulting in an altered ratio of AT1 to AT2 early after transplantation. There was no correlation between Ang II receptor levels and left ventricular wall thickness, and the decrease in receptor level did not correlate with any hemodynamic parameters, cyclosporine blood levels, or plasma renin, Ang II or pANP, except for a negative correlation between AT2 mRNA and plasma renin (r = -0.49,p = 0.05). Conclusions: Contrary to our expectations, mRNA for both Ang II receptors was downregulated after heart transplantation. The cause of myocardial hypertrophy after heart transplantation is still unclear, but the hypertrophy does not appear to be driven by increased transcription of the AT1 receptor.

AB - Objective: Cardiac hypertrophy appears early after heart transplantation, and may represent a myocardial response to injury. Recent evidence suggests that angiotensin II (Ang II) may promote growth through the AT1 and inhibit growth through the AT2 receptor subtypes. We therefore asked whether hypertrophy after heart transplantation is characterized by alterations in Ang 11 receptor gene expression. Methods: The expression of Ang II receptor subtypes, AT1 and AT2, was analyzed in right ventricular endomyocardial biopsies taken from 10 human donor hearts prior to implantation (controls) and from 17 heart transplant recipients, 11 studied during annual evaluation (> 1 year after transplantation) and 6 one week after transplantation. Competitive reverse transcription polymerase chain reaction (RT-PCR) was performed using synthetic RNA internal standards for both receptor subtypes. Results: AT1 and AT2 receptor mRNAs were detected in all samples. AT1 receptor mRNA decreased 4.5 fold (p < 0.01) and AT2 receptor mRNA 4.2 fold (p < 0.001) in transplant patients compared with controls. In the subgroup of patients examined one week after surgery AT1 was reduced relative to AT2 receptor mRNA, resulting in an altered ratio of AT1 to AT2 early after transplantation. There was no correlation between Ang II receptor levels and left ventricular wall thickness, and the decrease in receptor level did not correlate with any hemodynamic parameters, cyclosporine blood levels, or plasma renin, Ang II or pANP, except for a negative correlation between AT2 mRNA and plasma renin (r = -0.49,p = 0.05). Conclusions: Contrary to our expectations, mRNA for both Ang II receptors was downregulated after heart transplantation. The cause of myocardial hypertrophy after heart transplantation is still unclear, but the hypertrophy does not appear to be driven by increased transcription of the AT1 receptor.

KW - Angiotensin

KW - Clinical

KW - Gene expression

KW - Heart

KW - Human

KW - Molecular biology

KW - Receptors

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=17144464604&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17144464604&partnerID=8YFLogxK

U2 - 10.1016/S0008-6363(98)00015-7

DO - 10.1016/S0008-6363(98)00015-7

M3 - Article

C2 - 9709394

AN - SCOPUS:17144464604

VL - 38

SP - 340

EP - 347

JO - Cardiovascular Research

JF - Cardiovascular Research

SN - 0008-6363

IS - 2

ER -